Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121387) titled 'A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer' on Aug. 6.

Study Type: Observational

Primary Sponsor: Shanghai Pulmonary Hospital, Shanghai, China

Condition: SMARCA4-Deficient Tumor NSCLC (Advanced Non-small Cell Lung Cancer)

Recruitment Status: Not recruiting

Date of First Enrollment: January 1, 2020

Target Sample Size: 221

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07121387

Published by HT Digital Content Services with permission from Health Daily Digest....